This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jul;121(1):4-5.

doi: 10.1097/ALN.0000000000000286.

Ketamine metabolomics in the treatment of major depression

Monique van Velzen¹, Albert Dahan

Affiliations

PMID: 24936919
DOI: 10.1097/ALN.0000000000000286

Comment

Ketamine metabolomics in the treatment of major depression

Monique van Velzen et al. Anesthesiology. 2014 Jul.

. 2014 Jul;121(1):4-5.

doi: 10.1097/ALN.0000000000000286.

Authors

Monique van Velzen¹, Albert Dahan

Affiliation

¹ From the Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.

PMID: 24936919
DOI: 10.1097/ALN.0000000000000286

No abstract available

PubMed Disclaimer

Comment on

(R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function.
Paul RK, Singh NS, Khadeer M, Moaddel R, Sanghvi M, Green CE, O'Loughlin K, Torjman MC, Bernier M, Wainer IW. Paul RK, et al. Anesthesiology. 2014 Jul;121(1):149-59. doi: 10.1097/ALN.0000000000000285. Anesthesiology. 2014. PMID: 24936922 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations